176 related articles for article (PubMed ID: 18474771)
1. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides.
Albert DM; Gangnon RE; Grossniklaus HE; Green WR; Darjatmoko S; Kulkarni AD
Arch Ophthalmol; 2008 May; 126(5):626-31. PubMed ID: 18474771
[TBL] [Abstract][Full Text] [Related]
2. A study of iridectomy histopathologic features of latanoprost- and non-latanoprost-treated patients.
Albert DM; Gangnon RE; Zimbric ML; Damico CM; Fisher MR; Gleiser J; Grossniklaus HE; Green WR
Arch Ophthalmol; 2004 Nov; 122(11):1680-5. PubMed ID: 15534130
[TBL] [Abstract][Full Text] [Related]
3. Morphometric effects of long-term exposure to latanoprost.
Cracknell KP; Grierson I; Hogg P
Ophthalmology; 2007 May; 114(5):938-48. PubMed ID: 17292473
[TBL] [Abstract][Full Text] [Related]
4. Analysis of irises with a latanoprost-induced change in iris color.
Arranz-Marquez E; Teus MA; Saornil MA; Mendez MC; Gil R
Am J Ophthalmol; 2004 Oct; 138(4):625-30. PubMed ID: 15488791
[TBL] [Abstract][Full Text] [Related]
5. Latanoprost-induced iris darkening: a morphometric study of human peripheral iridectomies.
Cracknell KP; Grierson I; Hogg P; Appleton P; Pfeiffer N
Exp Eye Res; 2003 Dec; 77(6):721-30. PubMed ID: 14609560
[TBL] [Abstract][Full Text] [Related]
6. Histology and fine structure of the iris and outflow system following latanoprost therapy.
Grierson I; Pfeiffer N; Cracknell KP; Appleton P
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S176-84. PubMed ID: 12204715
[TBL] [Abstract][Full Text] [Related]
7. Iris morphology.
Teus MA; Arranz-Marquez E
Ophthalmology; 2008 Feb; 115(2):418-9; author reply 419-20. PubMed ID: 18243921
[No Abstract] [Full Text] [Related]
8. Fine structural evaluation of the iris after unilateral treatment with latanoprost in patients undergoing bilateral trabeculectomy (the Mainz II study).
Pfeiffer N; Grierson I; Goldsmith H; Appleton P; Hochgesand D; Winkgen A
Arch Ophthalmol; 2003 Jan; 121(1):23-31. PubMed ID: 12523881
[TBL] [Abstract][Full Text] [Related]
9. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color.
Wistrand PJ; Stjernschantz J; Olsson K
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S129-38. PubMed ID: 9154289
[TBL] [Abstract][Full Text] [Related]
10. Iridial pigmentation induced by latanoprost ophthalmic solution in Japanese glaucoma patients.
Chiba T; Kashiwagi K; Kogure S; Abe K; Shibuya T; Furuichi M; Iijima H; Tsukahara S
J Glaucoma; 2001 Oct; 10(5):406-10. PubMed ID: 11711839
[TBL] [Abstract][Full Text] [Related]
11. Latanoprost stimulates eumelanogenesis in iridial melanocytes of cynomolgus monkeys.
Prota G; Vincensi MR; Napolitano A; Selen G; Stjernschantz J
Pigment Cell Res; 2000 Jun; 13(3):147-50. PubMed ID: 10885672
[TBL] [Abstract][Full Text] [Related]
12. Latanoprost-induced iris heterochromia and open-angle glaucoma: a clinicopathologic report.
Tsai JC; Sivak-Callcott JA; Haik BG; Zhang J; McLean IW
J Glaucoma; 2001 Oct; 10(5):411-3. PubMed ID: 11711840
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin-induced iridial pigmentation in primates.
Selén G; Stjernschantz J; Resul B
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S125-8. PubMed ID: 9154288
[TBL] [Abstract][Full Text] [Related]
14. Latanoprost-induced changes in the iris and trabeculum: an electron-microscopic morphological study.
Yildirim N; Sahin A; Kara S; Baycu C
Int Ophthalmol; 2010 Feb; 30(1):93-7. PubMed ID: 19139827
[TBL] [Abstract][Full Text] [Related]
15. Latanoprost-induced iris color darkening: a case report with long-term follow-up.
Camras CB; Neely DG; Weiss EL
J Glaucoma; 2000 Feb; 9(1):95-8. PubMed ID: 10708238
[TBL] [Abstract][Full Text] [Related]
16. Latanoprost and pigmentation.
Grierson I; Jonsson M; Cracknell K
Jpn J Ophthalmol; 2004; 48(6):602-12. PubMed ID: 15592791
[TBL] [Abstract][Full Text] [Related]
17. The color of the human eye: a review of morphologic correlates and of some conditions that affect iridial pigmentation.
Imesch PD; Wallow IH; Albert DM
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S117-23. PubMed ID: 9154287
[TBL] [Abstract][Full Text] [Related]
18. Mechanism and clinical significance of prostaglandin-induced iris pigmentation.
Stjernschantz JW; Albert DM; Hu DN; Drago F; Wistrand PJ
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S162-75. PubMed ID: 12204714
[TBL] [Abstract][Full Text] [Related]
19. Comparison of iridial pigmentation between latanoprost and isopropyl unoprostone: a long term prospective comparative study.
Chiba T; Kashiwagi K; Chiba N; Ishijima K; Furuichi M; Kogure S; Abe K; Tsukahara S
Br J Ophthalmol; 2003 Aug; 87(8):956-9. PubMed ID: 12881333
[TBL] [Abstract][Full Text] [Related]
20. alpha-Methyl-p-tyrosine inhibits latanoprost-induced melanogenesis in vitro.
Drago F; Marino A; La Manna C
Exp Eye Res; 1999 Jan; 68(1):85-90. PubMed ID: 9986745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]